A Clinical Study in Three-arm of Lurbinectedin (PM01183) Alone or in Combination With Gemcitabine and a Control Arm With Docetaxel as Second Line Treatment in Non-Small Cell Lung Cancer (NSCLC) Patients
Clinical trial NCT01951157 · COMPLETED
Trial details
- NCT number
- NCT01951157
- Sponsor
- PharmaMar
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-11
- Primary completion
- 2016-11-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.